These data confirmed the generation of intact anti-CSPG4-IgG1 able to be internalized in CSPG4-high expressing melanoma cells, but less so in CSPG4-low expressing melanoma or breast cancer cell lines. This evidence concerns the gene CSPG4 and breast carcinoma.